
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Wednesday Oct 05, 2022
Wednesday Oct 05, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the pathophysiology of cold agglutinin disease (CAD), the steps needed for an accurate diagnosis, and how emerging treatment options are changing the management of patients with primary CAD.
The experts
- Prof. Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA,
- Prof. Bernd Jilma, Medical University of Vienna, Austria,
- Dr Shirley D'Sa, University College London Hospitals, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/understanding-the-immunopathogenesis-of-cad-what-are-the-implications-of-new-and-emerging-therapies

Monday Oct 03, 2022
Monday Oct 03, 2022
touchCONGRESS for touchONCOLOGY
Listen to urological cancer expert Prof. Axel Merseburger (Germany) review key data presented at ESMO 2022 exploring recent advances in immunotherapies and targeted treatments for patients with bladder cancer. He then offers his views on the potential impact of these data on clinical practice, alongside expert insights from Dr Bradley McGregor (USA) and Prof. Andrea Necchi (Italy).
OVERVIEW
Data Review with Prof. Merseburger (00:00)
Expert interviews with Prof. Merseburger, Dr McGregor and Prof. Necchi answering the questions below
INTERVIEW QUESTIONS
- Based on data recently presented at ESMO 2022, how do you think new and emerging immunotherapy agents and targeted treatments for patients with bladder cancer will impact the treatment landscape? (31:45)
- How can key learnings from ESMO 2022 be integrated into clinical practice when choosing between available regimens? (37:42)
- How is our understanding of the role of PD-L1 as a biomarker in bladder cancer evolving in light of recent data, and what are the possible implications for clinical practice? (44:35)
- What unmet needs remain surrounding biomarkers beyond PD-L1 in bladder cancer, and what are the prospects for biomarker-driven individualized treatment decisions in future? (51:14)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Seagen Inc. and Astellas Pharma Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/bladder-cancer-esmo2022-touchcongress/https://touchoncologyime.org/bladder-cancer-esmo2022-touchcongress/

Thursday Sep 29, 2022
Thursday Sep 29, 2022
touchMDT for touchNEUROLOGY
Listen to a patient advocate and person living with MS and two MS specialist neurologists discuss the importance of understanding the needs and preferences of patients at each treatment decision-making moment.
The multidisciplinary team
- Patient advocate/person living with MS: Ms Nele Handwerker, Germany
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:

Thursday Sep 29, 2022
Imaging disease progression in MS
Thursday Sep 29, 2022
Thursday Sep 29, 2022
touchMDT for touchNEUROLOGY
Listen to an imaging specialist and two neurologists specializing in MS care discuss the imaging modalities available to assess disease progression in MS.
The multidisciplinary team
- Imaging specialist: Dr Francesca Bagnato, USA
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurology.com/cme/integrating-practice-to-enhance-ms-patient-care/

Thursday Sep 29, 2022
Managing MS in patients over their lifetime
Thursday Sep 29, 2022
Thursday Sep 29, 2022
touchMDT for touchNEUROLOGY
Listen to two neurologists specializing in MS care discuss the management of MS throughout the lifetime of patients and consider treatment switching strategies at key milestones (e.g. during the paediatric, childbearing and elderly years).
The experts
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurology.com/cme/integrating-practice-to-enhance-ms-patient-care/

Wednesday Sep 28, 2022
Wednesday Sep 28, 2022
touchIN CONVERSATION for touchONCOLOGY
Listen to two breast cancer experts, Prof. Peter Schmid and Dr Marleen Kok discuss the mechanisms of action and latest data for emerging treatment options and how they are changing the management of metastatic triple negative breast cancer (mTNBC). The discussion is guided by pre-canvassed questions from the breast cancer clinical community.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Gilead and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-treatment-landscape-in-mtnbc/

Tuesday Sep 27, 2022
Tuesday Sep 27, 2022
touchMDT for touchRESPIRATORY
Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/

Tuesday Sep 27, 2022
Tuesday Sep 27, 2022
touchMDT for touchRESPIRATORY
Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/

Tuesday Sep 27, 2022
Mapping an individualized treatment plan: What role does the MDT play?
Tuesday Sep 27, 2022
Tuesday Sep 27, 2022
touchMDT for touchRESPIRATORY
Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/

Tuesday Sep 27, 2022
Tuesday Sep 27, 2022
touchMDT for touchRESPIRATORY
Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/